Differential DNA methylation associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review
- PMID: 38594575
- PMCID: PMC11003906
- DOI: 10.1007/s10143-024-02381-5
Differential DNA methylation associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review
Abstract
Recent studies suggest that differential DNA methylation could play a role in the mechanism of cerebral vasospasm (CVS) and delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH). Considering the significance of this matter and a lack of effective prophylaxis against DCI, we aim to summarize the current state of knowledge regarding their associations with DNA methylation and identify the gaps for a future trial. PubMed MEDLINE, Scopus, and Web of Science were searched by two authors in three waves for relevant DNA methylation association studies in DCI after aSAH. PRISMA checklist was followed for a systematic structure. STROBE statement was used to assess the quality and risk of bias within studies. This research was funded by the National Science Centre, Poland (grant number 2021/41/N/NZ2/00844). Of 70 records, 7 peer-reviewed articles met the eligibility criteria. Five studies used a candidate gene approach, three were epigenome-wide association studies (EWAS), one utilized bioinformatics of the previous EWAS, with two studies using more than one approach. Methylation status of four cytosine-guanine dinucleotides (CpGs) related to four distinct genes (ITPR3, HAMP, INSR, CDHR5) have been found significantly or suggestively associated with DCI after aSAH. Analysis of epigenetic clocks yielded significant association of lower age acceleration with radiological CVS but not with DCI. Hub genes for hypermethylation (VHL, KIF3A, KIFAP3, RACGAP1, OPRM1) and hypomethylation (ALB, IL5) in DCI have been indicated through bioinformatics analysis. As none of the CpGs overlapped across the studies, meta-analysis was not applicable. The identified methylation sites might potentially serve as a biomarker for early diagnosis of DCI after aSAH in future. However, a lack of overlapping results prompts the need for large-scale multicenter studies. Challenges and prospects are discussed.
Keywords: Aneurysmal subarachnoid hemorrhage; Cerebral vasospasm; DNA methylation; Delayed cerebral ischemia; Epigenetic changes; Intracranial aneurysm.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Lipid peroxidation metabolites as biomarkers in patients with aneurysmal subarachnoid hemorrhage and cerebral vasospasm or delayed cerebral ischemia: a systematic review.Neurosurg Rev. 2025 Jun 20;48(1):516. doi: 10.1007/s10143-025-03662-3. Neurosurg Rev. 2025. PMID: 40540084 Free PMC article. Review.
-
Role of Genetic Polymorphisms in Predicting Delayed Cerebral Ischemia and Radiographic Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.World Neurosurg. 2015 Oct;84(4):933-41.e2. doi: 10.1016/j.wneu.2015.05.070. Epub 2015 Jun 11. World Neurosurg. 2015. PMID: 26074429
-
Nicardipine Prolonged Release Implants for Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.J Stroke Cerebrovasc Dis. 2021 Oct;30(10):106020. doi: 10.1016/j.jstrokecerebrovasdis.2021.106020. Epub 2021 Aug 5. J Stroke Cerebrovasc Dis. 2021. PMID: 34365121
-
Volatile Sedation in Neurointensive Care Patients After Aneurysmal Subarachnoid Hemorrhage: Effects on Delayed Cerebral Ischemia, Cerebral Vasospasm, and Functional Outcome.World Neurosurg. 2024 Nov;191:e214-e226. doi: 10.1016/j.wneu.2024.08.097. Epub 2024 Aug 23. World Neurosurg. 2024. PMID: 39182830
-
Clinical Evidence for Intravenous Milrinone to Treat Secondary Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage-A Narrative Review.Acta Neurochir Suppl. 2025;136:3-9. doi: 10.1007/978-3-031-89844-0_1. Acta Neurochir Suppl. 2025. PMID: 40632248 Review.
Cited by
-
Comment on, "Differential DNA methylation associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review".Neurosurg Rev. 2024 Sep 23;47(1):666. doi: 10.1007/s10143-024-02914-y. Neurosurg Rev. 2024. Retraction in: Neurosurg Rev. 2025 Jan 29;48(1):101. doi: 10.1007/s10143-025-03265-y. PMID: 39311972 Retracted.
-
Lipid peroxidation metabolites as biomarkers in patients with aneurysmal subarachnoid hemorrhage and cerebral vasospasm or delayed cerebral ischemia: a systematic review.Neurosurg Rev. 2025 Jun 20;48(1):516. doi: 10.1007/s10143-025-03662-3. Neurosurg Rev. 2025. PMID: 40540084 Free PMC article. Review.
References
-
- Vlak MH, Algra A, Brandenburg R, Rinkel GJ (2011) Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol 10(7):626–636 - PubMed
-
- Khorasanizadeh M, Pettersson SD, Maglinger B, Garcia A, Wang SJ, Ogilvy CS (2023) Trends in the size of treated unruptured intracranial aneurysms over 35 years. J Neurosurg 139(5):1328–1338 - PubMed
-
- Pettersson SD, Khorasanizadeh M, Maglinger B, Garcia A, Wang SJ, Taussky P, Ogilvy CS (2023) Trends in the Age of Patients Treated for Unruptured Intracranial Aneurysms from 1990 to 2020. World Neurosurg 178(233–40):e13 - PubMed
-
- Etminan N, Chang HS, Hackenberg K, de Rooij NK, Vergouwen MDI, Rinkel GJE, Algra A (2019) Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: A systematic review and meta-analysis. JAMA Neurol 76(5):588–597 - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous